1.2 mg + 3 mg
Sponsors
MEDICE Arzneimittel Puetter GmbH & Co. KG
Conditions
acute pharyngitis
Phase 3
A prospective, multi-centre, randomised, double-blind, placebo-controlled Phase III trial to investigate the efficacy and safety of lozenges with benzydamine hydrochloride and dichlorobenzyl alcohol in the symptomatic treatment of patients suffering from acute pharyngitis
WithdrawnCTIS2025-521764-35-00
Target: 810Updated: 2025-09-19
A prospective, randomised, multi-centre, double-blind, placebo-controlled Phase III trial to investigate the efficacy and safety of lozenges with benzydamine hydrochloride and dichlorobenzyl alcohol in the symptomatic treatment of patients suffering from acute pharyngitis
Not yet recruitingCTIS2025-521764-35-01
Target: 810Updated: 2026-01-20